CME Information
Provider Statement: This continuing medical education activity is provided by 
.
Support Statement: This activity is supported by educational grants from Allergan, Inc.; Bausch + Lomb; and Shire.
Target Audience: The intended audience for this activity is comprehensive ophthalmologists and other health care professionals involved in the treatment of patients with disorders of the ocular surface.
Learning Objectives: Upon successful completion of this activity, participants should be better able to:
- Review the etiology and pathophysiology of dry eye disease and ocular surface disorders.
- Summarize new methods to diagnose ocular surface disorders.
- Describe the mechanisms of action of therapy used to treat ocular surface disorders.
- Assess the rationale for treatment selection for ocular surface disorders based on patient presentation.
Activity Chair:
Terry Kim, MD
Professor of Ophthalmology
Duke University School of Medicine
Chief, Cornea and External Disease Division
Director, Refractive Surgery Service
Duke University Eye Center
Durham, NC
Faculty:
Eric D. Donnenfeld, MD
Ophthalmic Consultants of Long Island
Clinical Professor of Ophthalmology
New York University
Trustee, Dartmouth Medical School
New York, NY
Lisa M. Nijm, MD, JD
Assistant Clinical Professor of Ophthalmology
University of Illinois Eye and Ear Infirmary
Warrenville EyeCare and LASIK
Medical Director
Cornea, External Disease and Refractive Surgery
Chicago, IL
Elizabeth Yeu, MD
Assistant Professor of Ophthalmology
Eastern Virginia Medical School
Partner, Virginia Eye Consultants
Cornea, Cataract, Anterior Segment, and Refractive Surgery Specialist
Norfolk, VA
Reviewer:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Accreditation:
Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation:
Vindico Medical Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This enduring material is approved for 1 year from the date of original release, April 24, 2018 through April 23, 2019.
How to Participate in this Activity and Obtain CME Credit:
To participate in this CME activity, you must read the objectives, answer the pretest questions, review the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 4 out of 5 of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate.
Disclosures:
In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all CME providers are required to disclose to the activity audience the relevant financial relationships of the planners, teachers, and authors involved in the development of CME content. An individual has a relevant financial relationship if he or she has a financial relationship in any amount occurring in the last 12 months with a commercial interest whose products or services are discussed in the CME activity content over which the individual has control. Relationship information appears above.
The authors
disclose that they do have significant financial interests in any products or
class of products discussed directly or indirectly in this activity, including
research support.
Activity Chair and Faculty members report the following relationship(s):
Eric D. Donnenfeld, MD
Consulting Fee: Abbott Medical Optics, AcuFocus, Alcon, Allergan, AqueSys, Avedro, Bausch + Lomb, CRST, Beaver-Visitec, Elenza, Foresight, Glaukos, Icon Bioscience, Kala, Katena, LacriPen, LensGen, Mati Pharmaceuticals, Merck, MDBackline, Mimetogen, NovaBay, Novaliq, Ocuhub, Odyssey, Omega Ophthalmics, Omeros, Oyster Point Therapeutics, Pfizer, PogoTec, Physician Recommended Nutriceuticals, RPS, Shire, Strathspey Crown, Sun Pharmaceutical, TearLab, TLC Laser Centers, TrueVision, Veracity, Versant Ventures, Zeiss
Speakers Bureau: Abbott Medical Optics, AcuFocus, Alcon, Allergan, AqueSys, Bausch + Lomb, Beaver-Visitec, CRST, Elenza, Foresight, Glaukos, Icon Bioscience, Kala, Katena, LacriPen, LensGen, Mati Pharmaceuticals, Merck, Mimetogen, NovaBay, Novaliq, Odyssey, Omega Ophthalmics, OcuHub, Omeros, Pfizer, PogoTec, Physician Recommended Nutriceuticals, RPS, Shire, Strathspey Crown, Sun Pharmaceutical, TearLab, TLC Laser Centers, TrueVision, Versant Ventures, Zeiss
Ownership Interest: AcuFocus, AqueSys, Avedro, Elenza, Glaukos, LacriPen, LensGen, Mati Pharmaceuticals, MDBackline, Mimetogen, NovaBay, OcuHub, PogoTec, RPS, SARcode, Strathspey Crown, TearLab, TrueVision, Veracity, Versant Ventures, Visionary Ventures
Terry Kim, MD
Consulting Fee: Acucela, Aerie, Alcon/Novartis, Allergan/Actavis, Avedro, Avellino Labs, Bausch + Lomb/Valeant, BlephEx, CoDa/Ocunexus Therapeutics, Kala, NovaBay, Ocular Therapeutix, Omeros, PowerVision, Presbyopia Therapies, Shire, Sightlife Surgical, Simple Contacts, TearLab, TearScience
Ownership Interest: Kala, NovaBay, Ocular Therapeutix, Omeros, SightLife Surgical, Simple Contacts, TearScience
Lisa M. Nijm, MD, JD
Consulting Fee: Omeros, Shire
Speakers Bureau: Alcon
Elizabeth Yeu, MD
Speakers Bureau: Alcon, Allergan, ArcScan, Bausch + Lomb, Beaver Visitec, Bio-Tissue, iOptics, Johnson & Johnson Vision, LENSAR, Kala, Novartis, Ocular Science, Ocular Therapeutix, Ocusoft, Omeros, Science Based Health, Shire, SightLife, Sun Pharmaceutical, TearLab,TearScience, TopCon, Zeiss
Contracted Research: Alcon, Allergan, Bausch + Lomb, Bio-Tissue, iOptics, Ocular Science, Kala, TopCon
Ownership Interest: ArcScan, Modernizing Medicine, Ocular Science, SightLife, Strathspey Crown
Advisory Board: Alcon, Allergan, ArcScan, Bausch + Lomb, Bio-Tissue, iOptics, Johnson & Johnson Vision, Ocular Therapeutix, Ocusoft, SightLife, TearLab, TearScience
Reviewer reports the following relationships:
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relationship(s):
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance
Unlabeled and Investigational Usage:
The audience is advised that this continuing medical education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non-FDA approved or investigational use of products/devices.
Copyright Statement:
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2018 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any of Vindico Medical Education continuing medical education activities does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
CME Questions?
Contact us at cme@vindicoCME.com